Suppression of HIV replication by antiretroviral therapy reduces TIM-3 expression on HIV-specific CD8(+) T cells.
Kassu
Afework
A
Marcus
Roland A
RA
D'Souza
Michelle B
MB
Kelly-McKnight
Elizabeth A
EA
Palmer
Brent E
BE
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002478:Cells, Cultured; D015870:Gene Expression; D006678:HIV / Q000276:immunology* / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D000072597:Hepatitis A Virus Cellular Receptor 2; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000276:immunology / Q000821:virology; D008565:Membrane Proteins / Q000096:biosynthesis*; D014779:Virus Replication / Q000187:drug effects*
D019380:Anti-HIV Agents; C448908:HAVCR2 protein, human; D000072597:Hepatitis A Virus Cellular Receptor 2; D008565:Membrane Proteins